Transaction

Clearwater France advises Naxicap Partners, Ouest Croissance, the founder and the management in the disposal of Lilial to Coloplast

Transaction

Naxicap Partners, Ouest Croissance sold Lilial to Coloplast

Sell-side

Undisclosed

Role

Adviser to Naxicap Partners, Ouest Croissance on its sale of Lilial to Coloplast

Sector

Healthcare

Region

France & Belgium

Clearwater France has advised Naxicap Partners, Ouest Croissance, the founder and the management in the disposal of the company Lilial to Danish group Coloplast.

Founded in 2003 by Denis Marliac, Lilial is the French leader in the distribution of medical devices related to ostomy and urology. The company has approximately 80 employees and is expected to record sales of about € 33m for the full-year 2017.

Coloplast, a Danish listed group with a revenue of more than € 2bn, is one of the world leaders in the development and manufacturing of medical devices and services related to ostomy, continence, urology and wound care. The acquisition of Lilial will strengthen its distribution network in France.

Following a competitive process gathering French and international players, Coloplast’s offer has been retained by the sellers.

image 131

Clearwater has been very professional in leading the process involving candidates from all over the world.

Luc Bertholat, Partner, Naxicap Partners
image 131

We are very pleased to have advised Lilial shareholders on this transaction which gives the company an international foundation all while respecting its DNA.

Clearwater

Transactions